Provided herein are compounds of formula (A): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein X1, X2, X3, X4, Z1, Z2, Z3, Z4, Ra, Rb, Rc, Rd, Re, L, Y, andmare as defined herein. Also provided are methods of inhibiting APOL1 and methods of preparing compounds of formula (A). Also provided are methods of inhibiting APOL1 and methods of treating an APOL1 -mediated disease, disorder, or condition in an individual.
Provided herein are compounds of formula (A): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein X1, X2, X3, X4, Z1, Z2, Z3, Z4, Ra, Rb, Rc, Rd, Re, L, Y, andmare as defined herein. Also provided are methods of inhibiting APOL1 and methods of preparing compounds of formula (A). Also provided are methods of inhibiting APOL1 and methods of treating an APOL1 -mediated disease, disorder, or condition in an individual.
alkylation of sulfinicacids with sulfonamides has been developed via sp3 C−N bond cleavage at room temperature. In the absence of external catalysts and additives, a wide variety of N-benzylic and N-allylic sulfonamides couple with sulfinicacids to give structurally diversified sulfones in moderate to excellent yields. Furthermore, the reaction of N-(2-acyl)allylic sulfonamides with sulfinicacids provides